Plaque volume and plaque risk profile in diabetic vs. non-diabetic patients undergoing lipid-lowering therapy: a study based on 3D intravascular ultrasound and virtual histology.
Tomas KovarnikZhi ChenGary S MintzAndreas WahleKristyna BayerovaAles KralMartin ChvalKarel KoprivaJohn LopezMilan SonkaAles LinhartPublished in: Cardiovascular diabetology (2017)
Based on detailed 3D analysis, we found advanced plaque phenotype and further atherosclerosis progression in DM patients despite the same reached levels of LDLc as in non-DM patients. Trial registration ClinicalTrials.gov identifier: NCT01773512.
Keyphrases
- end stage renal disease
- patients undergoing
- newly diagnosed
- ejection fraction
- type diabetes
- chronic kidney disease
- coronary artery disease
- peritoneal dialysis
- prognostic factors
- magnetic resonance imaging
- randomized controlled trial
- computed tomography
- patient reported outcomes
- insulin resistance
- mesenchymal stem cells
- skeletal muscle
- glycemic control
- ultrasound guided
- phase ii
- patient reported